Doxiproct Plus
Doxiproct Plus is a medicine authorised by Swissmedic under authorisation number 38934. The authorisation holder is OM Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 April 1975 and the authorisation is valid without a time limit. ATC code C05AA09 places the medicine in the group Vasoprotectives.
| Authorisation number | 38934 |
|---|---|
| Name | Doxiproct Plus |
| Full name | Doxiproct Plus, pommade rectale |
| Authorisation holder | OM Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C05AA09 |
| First authorisation | 22 April 1975 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Doxiproct Plus, pommade rectale | B | 22 April 1975 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 15 | 20 | g | C05AA09 | 02.09.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Doxiproct Plus authorised in Switzerland?
Yes. Doxiproct Plus is authorised by Swissmedic under authorisation number 38934, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Doxiproct Plus have?
Doxiproct Plus is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Doxiproct Plus?
The authorisation holder is OM Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.